ONCY (Oncolytics Biotech) FCF Margin %: 0.00% (As of Mar. 2026)


ONCY Oncolytics Biotech Inc ONCY
31 GF Score
Price $0.92
! 2 Warning Signs
View Full Analysis

What is Oncolytics Biotech FCF Margin %?

Oncolytics Biotech ONCY -0.98% 31 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ONCY with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Oncolytics Biotech ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Oncolytics Biotech's Free Cash Flow for the three months ended in Mar. 2026 was $-7.30 Mil. Oncolytics Biotech's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Oncolytics Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Oncolytics Biotech's current FCF Yield % is -20.65%.

The historical rank and industry rank for Oncolytics Biotech's FCF Margin % or its related term are showing as below:


ONCY's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Oncolytics Biotech FCF Margin % Related Terms

Oncolytics Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Oncolytics Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncolytics Biotech FCF Margin % Chart

Oncolytics Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oncolytics Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ONCY vs ALPS, KLRS, BDTX: FCF Margin % Comparison

For the Biotechnology subindustry, Oncolytics Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncolytics Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolytics Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Oncolytics Biotech's FCF Margin % falls into.


ONCY
31GF Score
Oncolytics Biotech Inc ONCY
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncolytics Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Oncolytics Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-20.118/0
= %

Oncolytics Biotech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.299/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Oncolytics Biotech (ONCY) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Oncolytics Biotech and its competitors. According to the industry distribution chart, Oncolytics Biotech ranks #999999 out of 960 companies in the Biotechnology industry.
Is Oncolytics Biotech's FCF Margin % too high?
Oncolytics Biotech's current FCF Margin % is 0.00%. Based on the distribution chart, Oncolytics Biotech ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oncolytics Biotech has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Oncolytics Biotech's FCF Margin % compare to ALPS and KLRS?
According to the Biotechnology industry distribution chart, Oncolytics Biotech ranks #999999 out of 960 companies for FCF Margin %. This places Oncolytics Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Oncolytics Biotech and its competitors. Oncolytics Biotech's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncolytics Biotech stock overvalued right now?
Oncolytics Biotech (ONCY) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Oncolytics Biotech's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Oncolytics Biotech (ONCY), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncolytics Biotech Business Description

Address 4350 Executive Drive, Suite 325, San Diego, CA, USA, 92121
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
31GF Score

Get the complete analysis for ONCY

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.92
Price